Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis.
Saved in:
| Title: | Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis. |
|---|---|
| Authors: | Pariser DM; Eastern Virginia Medical School and Virginia Clinical Research, Inc., 6160 Kempsville Circle, Suite 200A, Norfolk, VA, 23502, USA. dpariser@pariserderm.com., Lain EL; Austin Institute for Clinical Research, Austin, TX, USA., Mamelok RD; Mamelok Consulting, Palo Alto, CA, USA., Drew J; Dermira, Inc., a wholly owned subsidiary of Eli Lilly and Company, Menlo Park, CA, USA., Mould DR; Projections Research, Inc., Phoenixville, PA, USA. |
| Source: | Clinical pharmacokinetics [Clin Pharmacokinet] 2021 May; Vol. 60 (5), pp. 665-676. Date of Electronic Publication: 2021 Jan 12. |
| Publication Type: | Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Adis, part of Springer Science+Business Media Country of Publication: Switzerland NLM ID: 7606849 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1926 (Electronic) Linking ISSN: 03125963 NLM ISO Abbreviation: Clin Pharmacokinet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1179-1926 |
|---|---|
| DOI: | 10.1007/s40262-020-00975-y |
